IRADIMED CORP (IRMD)
IRADIMED CORP (IRMD) from its SEC filings: 2025 revenue $83.8 million (+14% vs the year before), net margin 27%, free cash flow $17.2 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $83.8 million |
| Revenue growth | +14% |
| Net income | $22.5 million |
| Net margin | 26.8% |
| Free cash flow | $17.2 million |
| Diluted EPS | $1.75 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +0% |
| Cash | $59.1 million |
| Share count, 1 year | +1% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.